Manufacturer
Granules Pharmaceuticals Inc.
38 drugs, 121 product strengths, 11 recalls on record.
Drugs Granules Pharmaceuticals Inc. makes
Sertraline+0.8%Generic · 42 makersPharmacies pay from$0.852 open recallsGabapentin+4.5%Generic · 72 makersPharmacies pay from$0.667 open recallsBupropion-0.4%Generic · 62 makersPharmacies pay from$2.113 open recallsPantoprazole+2.7%Generic · 62 makersPharmacies pay from$1.103 open recallsVenlafaxine+0.3%Generic · 49 makersPharmacies pay from$2.14Methylphenidate-1.0%Generic · 28 makersPharmacies pay from$3.65Unavailable1 open recallEsomeprazole-3.4%Generic · 107 makersPharmacies pay from$3.844 open recallsIbuprofen+1.5%Generic · 240 makersPharmacies pay from$1.019 open recallsMetformin+2.2%Generic · 65 makersPharmacies pay from$0.44Being discontinued21 open recallsMetoprolol+1.0%Generic · 65 makersPharmacies pay from$0.48Being discontinued9 open recallsLosartan+1.5%Generic · 37 makersPharmacies pay from$0.6736 open recallsTrazodone-1.9%Generic · 31 makersPharmacies pay from$0.903 open recallsPotassium chloride+1.2%Generic · 60 makersPharmacies pay from$2.51Being discontinued2 open recallsAmphetamine+0.6%Generic · 10 makersPharmacies pay from$13.55In shortageCetirizine-4.2%Generic · 146 makersPharmacies pay from$1.365 open recallsLoratadine+3.5%Generic · 145 makersPharmacies pay from$1.641 open recallNaproxen-3.7%Generic · 145 makersPharmacies pay from$1.484 open recallsGuaifenesin-3.5%Generic · 144 makersPharmacies pay from$0.986 open recallsMethocarbamol-2.1%Generic · 57 makersPharmacies pay from$1.162 open recallsColchicine-2.6%Generic · 30 makersPharmacies pay from$3.57Amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate-2.4%Generic · 25 makersPharmacies pay from$6.81Unavailable6 open recallsLisdexamfetamine+6.8%Generic · 18 makersPharmacies pay from$74.56Limited availability8 open recallsAcetaminophen+1.6%Generic · 255 makersPharmacies pay from$0.6619 open recallsClotrimazole+0.4%Generic · 113 makersPharmacies pay from$3.556 open recallsFexofenadine-0.8%Generic · 96 makersPharmacies pay from$4.771 open recallAcetaminophen / ibuprofen-12.9%Generic · 51 makersPharmacies pay from$2.801 open recallGlycopyrronium-1.0%Generic · 49 makersPharmacies pay from$2.96Being discontinued4 open recallsAcetaminophen / butalbital / caffeine-1.2%Generic · 35 makersPharmacies pay from$3.622 open recallsAcetaminophen / hydrocodone-3.1%Generic · 31 makersPharmacies pay from$3.92Prazosin-0.5%Generic · 28 makersPharmacies pay from$2.49Being discontinued9 open recallsRamelteon+0.9%Generic · 27 makersPharmacies pay from$19.98Being discontinuedAcetaminophen / oxycodone-0.4%Generic · 23 makersPharmacies pay from$3.532 open recallsValganciclovir-3.8%Generic · 21 makersPharmacies pay from$55.24Dexmethylphenidate+13.0%Generic · 12 makersPharmacies pay from$5.67Trospium-2.2%Generic · 20 makersPharmacies pay from$6.201 open recallMethylergonovine+12.8%Generic · 12 makersPharmacies pay from$1521 open recallAcetaminophen / butalbital-3.4%Generic · 9 makersPharmacies pay from$16.54PenicillamineGeneric · 8 makersNo weekly price
Recalls
Class IIOngoingFeb 11, 2026Trazodone HydrochloridePresence of Foreign Tablets/CapsulesGranules Pharmaceuticals Inc. · D-0305-2026Class IIIOngoingOct 1, 2025Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications:Granules Pharmaceuticals Inc. · D-0669-2025Class IIIOngoingOct 1, 2025Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications:Granules Pharmaceuticals Inc. · D-0670-2025Class IIIOngoingOct 1, 2025Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications:Granules Pharmaceuticals Inc. · D-0671-2025Class IIIOngoingOct 1, 2025Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications:Granules Pharmaceuticals Inc. · D-0672-2025Class IIIOngoingOct 1, 2025Dextroamphetamine SaccharateFailed Impurities/Degradation Specifications:Granules Pharmaceuticals Inc. · D-0673-2025Class IIOngoingJul 9, 2025Metoprolol Succinate Extended-Release TabletsFailed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.Granules Pharmaceuticals Inc. · D-0510-2025Class IITerminatedJan 15, 2025Colchicine Capsules 0.6 mgFailed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.Granules Pharmaceuticals Inc. · D-0187-2025Class IITerminatedJan 15, 2025Metformin Hydrochloride Extended-Release TabletsPresence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.Granules Pharmaceuticals Inc. · D-0192-2025Class IITerminatedAug 14, 2024Gabapentin TabletsPresence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin TabletsGranules Pharmaceuticals Inc. · D-0634-2024Class IIOngoingJul 22, 2020Metformin Hydrochloride Extended-Release Tablets USPCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelGranules Pharmaceuticals Inc · D-1386-2020
About Granules Pharmaceuticals Inc.
No comments yet. Questions, tips, what worked for you - start the conversation.